ShrimpNew aquaculture joint venture wants to replace antibiotic use with probiotics technologyThe manufacturing facility is anticipated to begin operations early 2025."This partnership positions us to provide probiotics and enzymes to meet the surging global demand," Blue Aqua CEO and founder Farshad Shishehchian said.Photo: AICheHanna Gezelius